It has been previously demonstrated in breast cancer and glioblastoma that PIK3CA mutations and PTEN loss are virtually mutually exclusive, suggesting that abrogation of just one of these proteins is sufficient for tumorigenesis [76,77]. The gene discussed is PIK3CA; the disease is breast cancer.